Noah Scheinfeld
St Luke's Roosevelt Hospital Center, Department of Dermatology, New York, NY 10029, USA.
J Drugs Dermatol. 2008 Apr;7(4):409-15.
A thorough knowledge of all topical antibiotics treatment options is important as more pathogens become resistant to standard therapies. As resistance to mupirocin increases, it seems that triple antibiotic ointments and retapamulin (the newest FDA-approved agent) will have greater roles in treating impetigo and skin infections. Awareness of all these agents provides a dermatologist additional tools with which to treat skin infections. As a wide variety of topical antibiotics, combination antibiotics, and combination anti-inflammatory preparations used by ophthalmologists are not part of the therapeutic armamentarium of most dermatologists, this review will provide the knowledge needed to rationally use such ophthalmologic preparations. Finally, information related to the topical nadifloxacin for acne and skin infections, which is in clinical use in Japan, is summarized.
随着越来越多的病原体对标准疗法产生耐药性,全面了解所有局部用抗生素的治疗选择至关重要。随着对莫匹罗星耐药性的增加,三联抗生素软膏和瑞他帕林(最新获得美国食品药品监督管理局批准的药物)在治疗脓疱病和皮肤感染方面似乎将发挥更大作用。了解所有这些药物为皮肤科医生提供了更多治疗皮肤感染的工具。由于眼科医生使用的多种局部用抗生素、联合抗生素和联合抗炎制剂并非大多数皮肤科医生治疗药物的一部分,本综述将提供合理使用此类眼科制剂所需的知识。最后,总结了在日本临床使用的局部用萘啶酸治疗痤疮和皮肤感染的相关信息。